CAH Quantitative Stock Analysis | Nasdaq

From Nasdaq: 2025-05-24 13:16:00

Validea’s guru fundamental report for CARDINAL HEALTH INC (CAH) shows it rates highest with a score of 100% using the Multi-Factor Investor model based on Pim van Vliet’s strategy. CAH is a large-cap growth stock in the Major Drugs industry. The stock meets the criteria for market cap and standard deviation, but is neutral on twelve minus one momentum and net payout yield. Pim van Vliet’s research shows that low volatility stocks outperform high volatility stocks with less risk. Validea offers investment research services based on strategies of investment legends like Warren Buffett and Peter Lynch.



Read more at Nasdaq: CAH Quantitative Stock Analysis | Nasdaq